Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
1
33%
Ph phase_2
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Completed1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
not_yet_recruiting133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingearly_phase_1

SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes

NCT07409714
recruitingphase_2

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

NCT06747130
completednot_applicable

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

NCT00655616

Clinical Trials (3)

Showing 3 of 3 trials
NCT07409714Early Phase 1

SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes

Not Yet Recruiting
NCT06747130Phase 2

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Recruiting
NCT00655616Not Applicable

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3